Given its essential role in DNA synthesis, DHFR is a target for several anticancer drugs, such as methotrexate. These drugs inhibit DHFR, thereby blocking DNA synthesis and cell division, which can slow down or stop the growth of cancer cells. However, the inhibition of DHFR can also affect normal cells, leading to side effects such as bone marrow suppression and gastrointestinal toxicity.
